{"version":"1.0","type":"link","title":"An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer.","author_name":"Grochot R 외","author_url":"https://prs-insight.online/author/Grochot%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/131360","thumbnail_width":1200,"thumbnail_height":630}